2015, Number 5
<< Back Next >>
Rev Med Inst Mex Seguro Soc 2015; 53 (5)
Stages of grief in diabetes and metabolic control
Rodríguez-Moctezuma JR, López-Delgado ME, Ortiz-Aguirre AR, Jiménez-Luna J, López-Ocaña LR, Chacón-Sánchez J
Language: Spanish
References: 17
Page: 546-551
PDF size: 272.20 Kb.
ABSTRACT
Background: To identify type 2 diabetic patients, the stages of grief and
its association with metabolic control.
Methods: 186 patients both sexes, without recent loss of a loved one or
a terminal illness. We applied a previously validated instrument, which
explored the stages of grief (denial, anger/disbelief, bargaining, depression,
and acceptance). There was measured BMI, waist circumference,
and 6-month averages of glucose, cholesterol and triglycerides.
Results: The associations between the stages of grief and clinical variables
showed that BMI is greater denial 33.1 ± 6.2 vs 28.9 ± 4.6 33.1
with
p = 0.001, in disbelief stage glucose is greater 190 ± 67 vs 167 ± 51
with
p ‹ 0.05. The negotiation phase is associated with older age, 65.6 ±
10 vs 59.1 ± 11 years with
p = 0.001 and higher cholesterol level against
229.4 ± 39.1 vs 206.6 ± 40 with
p ‹ 0.05. The stage of depression was
associated with increased diagnostic time vs. 13.3 ± 8.9 vs 9.4 ± 7.1
years with
p ‹ 0.05 and the blood glucose level 198.9 ± 60, vs 164 ± 51
mg/dL
p = 0.001
Conclusions: There are logical associations between clinical variables
and stages of grief. Identify the stages of grief, as an additional element
in the evaluation of patients with diabetes will develop strategies
to improve adherence to medical management and metabolic control.
REFERENCES
Encuesta Nacional de Salud 2000. Programa de acción: Diabetes Mellitus 1ª edición 2001-11-22 Secretaría de Salud
Programa Nacional de Salud 2007-2012. Secretaría de Salud (SSA), Instituto de Seguridad y Servicios Sociales para los Trabajadores del Estado (ISSSTE), Petróleos Mexicanos, Instituto Mexicano del Seguro Social (IMSS), Sistema Nacional de Desarrollo Integral de la Familia (DIF),Secretaria de la Defensa Nacional.
Sistema Único de Información IMSS 27, 13 Costo de la consulta y hospitalización: División de Desarrollo e Integración de Sistemas, costo unitario al mes de mayo del 2005.
M. Jansá, M. Vidal. The importance of adherence to the treatment in diabetes mellitus. Av Diabetol 2009;25:55-61
J.M. López-Carmona, J.R. Rodríguez-Moctezuma, C.R. Ariza-Andraca M. Martínez-Bermúdez. Estilo de vida y control metabólico en pacientes con diabetes mellitus tipo 2. Validación por constructo del IMEVID. Aten Primaria 2004;33(1):20-7
UKPDS 33. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 1998;352: 837-853
Rodríguez-Moctezuma, Magdaleno-Tobías ME, Munguía-Miranda C, Hernández Santiago JL, Casas de la Torre E. Factores de los médicos familiares asociados al control glucémico de sus pacientes con diabetes mellitus. Gác Méd Méx 2003;139:112-17.
A. Carcavilla Urquí. Atención al paciente con diabetes. Algo más que insulinas. Rev Pediatr Aten Primaria. 2009;11 Supl 16:s217-s238
Dohrenwend BS, Krasnoff L, Askenasy AR, Dohrenwend BP. The Psychiatric Epidemiology Research Interview Life Events Scale. En: Mezzich JE, Jorge MR, Salloum IM, eds. Psychiatric Epidemiology. Baltimore: The Johns Hopkins University Press; 1994. P: 401-36.
Kubler-Ross, E. On death and dying. Nueva York: Routledge,1973 ISBN 0-415-04015-9.
Jacobs S, Hansen F, Kasl S, Ostfeld A, Berkman I, Kim K. Anxiety disorders during acute bereavement: risk and risk factors. J Clin Psychiatry 1990;51:269-74.
Isla-Pera P, Moncho-Vasallo J, Guasch-Andreu O, Torras-Rabasa A. Proceso de adaptación a la diabetes mellitus tipo 1 (DM1). Concordancia con las etapas del proceso de duelo descrito por Kübler- Ross. Endocrinol Nutr. 2008;55(2):78-83
Jennifer Janetski, MS, RD, CDE Living on the Edge of Diabetes: How to Integrate the Diabetes Prevention Program into a Community Setting. Diabetes Spectrum 2009;22(3):179-182
Ortiz M, Ortiz E, Gatica A, Gómez D. Factores psicosociales asociados a la adherencia al tratamiento de la diabetes tipo 2. Terapia Psicológica 2011;29 (1):5-11
Duelo: Evaluación, diagnóstico y tratamiento. Gil- Juliá B, Belliver A, Bellester R. Psicooncologia 2008; 5(1):103-106
Chimal-Morales I, López-Aispuro AC. Identificación de factores desencadenantes del descontrol metabólico agudo grave en pacientes con diabetes mellitus tipo 2. Rev Sanid Milit Mex 2010;64(2):49-53.
Guerrero-Angulo ME, Padierna-Luna JL. Descontrol metabólico en diabetes tipo 2. Rev Med Inst Mex Seguro Soc 2011;49(4):419-424
Full text